A Phase I Study of Irinotecan and Temozolomide with Bevacizumab in Children with Recurrent/Refractory Central Nervous System Tumors

Metts, J., Harrington, B., Salman, E., Bradfield, S. M., Flanary, J., Mosha, M., Amankwah, E., & Stapleton, S. (2022). A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors. Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery38(5), 919–928. https://doi.org/10.1007/s00381-022-05479-7

Category